4
FOR HEALTHCARE PROFESSIONALS
IMPORTANT HEALTH AND SAFETY
INFORMATION:
DO NOT use the TRUE2go System for patients
receiving the following treatments:
•
Peritoneal dialysis using solutions containing
icodextrin (Extraneal
®
, Icodial
®
) that is
metabolized to maltose,
•
Injections or infusions of solutions containing
galactose or maltose, including some human
immunoglobulin preparations (Octagam
®
, WinRho
®
,
SDF Liquid, HepaGam B
™
),
•
Xylose absorption testing,
•
Intravenous solutions containing maltose,
•
Any drugs that contain or metabolize to maltose,
galactose, or xylose (Orencia
®
, Adept
®
, Bexxar
®
).
Using the TRUE2go System when receiving
the above treatments may cause false high
glucose results.
4
False high results may lead
to inappropriate therapy, which may result
in coma or death. For more information see
www.fda.gov/BiologicsBloodVaccines/
SafetyAvailability/ucm154213.htm
T2g_OB_GutsENG_F4NPD04r21.indd 4 12/21/11 9:56 AM
To Next Page
Loading...
